Shows & Panels
- AFCEA Answers
- Ask the CIO
- The Big Data Dilemma
- Carrying On with Continuity of Operations
- Connected Government
- Constituent Servicing
- Continuous Monitoring: Tools and Techniques for Trustworthy Government IT
- The Cyber Imperative
- Cyber Solutions for 2013 and Beyond
- Expert Voices
- Federal Executive Forum
- Federal IT Challenge
- Federal Tech Talk
- Mission-critical Apps in the Cloud
- The Path from Legacy Systems
- The Real Deal on Digital Government
- The Reality of Continuous Monitoring... Is Your Agency Secure?
- Veterans in Private Sector: Making the Transition
Shows & Panels
Analysis: White House prescription drug proposal could mean fewer options
Tuesday - 10/25/2011, 5:14pm EDT
Currently, OPM contracts with pharmacy benefits managers who negotiate drug prices. The administration said the change proposed in its letter to the supercommittee would offer lower prescription drug prices to federal employees and save the government $1.6 billion over the next decade.
But, in an interview with In Depth with Francis Rose, Robert Moffit, senior fellow at the Heritage Foundation's Center for Policy Innovation, said the White House's projected savings are a "very, very strange number."
In its proposal to the supercommittee, the White House said FEHBP pays $40 billion per year for health coverage and drugs represent 30 percent. Over the next decade, drugs would cost $120 billion, so the $1.6 billion savings is a mere 2 percent of drug expenditures, Moffit pointed out.
Lower costs for feds will also mean less options, he said.
"What you've got to worry about is OPM cracking down on the drugs that are available to you in order to get savings," Moffit said.
He said his concern is the OPM's negotiations would then become a larger issue of "congressional micro-management."
For now, the details of how the administration's proposal would work are not clear. The letter to the supercommittee only contains one paragraph on the proposal.
The Congressional Spotlight is brought to you by United Technologies Corporation.